Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Paola, Scarparo"'
Autor:
Wijnand K. den Dekker, Anastasios-Alexandros Siskos, Jeroen M. Wilschut, Rutger-Jan Nuis, Paola Scarparo, Tara Neleman, Kaneshka Masdjedi, Jurgen M. R. Ligthart, Roberto Diletti, Joost Daemen, Nicolas M. Van Mieghem
Publikováno v:
Netherlands Heart Journal, 31(5), 196-201. Bohn Stafleu van Loghum
Background In January 2021, the Diamondback 360 orbital atherectomy (OA) system received CE mark approval and became available in Europe. The first procedure in Europe was performed at the Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd45b5ee9af910f1f4faaa01391d9295
https://pure.eur.nl/en/publications/eb38764e-5484-48b2-a41e-fe60fb1b27e5
https://pure.eur.nl/en/publications/eb38764e-5484-48b2-a41e-fe60fb1b27e5
Autor:
Jacob Joseph Elscot, Hala Kakar, Paola Scarparo, Wijnand K Den Dekker, Johan R Bennett, Carl E Schotborgh, Rene J van der Schaaf, Manel Sabaté, Raúl Moreno, Koen Ameloot, Rutger J van Bommel, Daniele Forlani, Bert Van Reet, Giovanni Esposito, Maurits Theodoor Dirksen, Willem P.T. Ruifrok, Bert R.C. Everaert, Carlos Van Mieghem, Eduardo Pinar-Bermúdez, Fernando Alfonso, Paul Cummins, Mattie J Lenzen, Salvatore Brugaletta, Joost Daemen, Eric Boersma, Nicolas M. Van Mieghem, Roberto Diletti
Background Multivessel coronary artery disease (MVD) is highly prevalent in patients presenting with non-ST-segment elevation myocardial infarction (NSTE-ACS) and is associated with worse clinical outcomes compared with single vessel disease patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc2e0c7112f5ddd008151a3ffa0b023f
https://doi.org/10.1101/2023.05.29.23290502
https://doi.org/10.1101/2023.05.29.23290502
Autor:
Jeroen Wilschut, Roberto Diletti, Joost Daemen, Paola Scarparo, Wijnand K den Dekker, Nicolas M. Van Mieghem, Riccardo Improta, Felix Zijlstra, Quinten Wolff
Publikováno v:
Catheterization and Cardiovascular Interventions, 99(1), 88-97. Wiley-Liss Inc.
Objectives To compare stent recoil (SR) of the thin-strut durable-polymer Zotarolimus-eluting stent (dp-ZES) and the ultrathin-strut bioabsorbable-polymer Sirolimus-eluting stent (bp-SES) in chronic total occlusions (CTOs) and to investigate the pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f1332cccc1b0000a3363428d98a3ccc
https://pure.eur.nl/en/publications/66b29067-11b6-4232-b31f-3e634f28c022
https://pure.eur.nl/en/publications/66b29067-11b6-4232-b31f-3e634f28c022
Autor:
Alessandra Scoccia, Paola Scarparo, Tara Neleman, Hala Kakar, Jeroen Wilschut, Wijnand K. Den Dekker, Felix Zijlstra, Nicolas M. Van Mieghem, Joost Daemen, Roberto Diletti
Publikováno v:
Catheterization and Cardiovascular Interventions, 100(6), 964-970. Wiley-Liss Inc.
Background: Angiography-based vessel fractional flow reserve (vFFR) demonstrated a strong correlation with invasive fractional flow reserve (FFR) in both a pre- and post-percutaneous coronary intervention (PCI) setting. However, the role of vFFR and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4a204a5041310ce081ad0366ee8d608
https://pubmed.ncbi.nlm.nih.gov/36321612
https://pubmed.ncbi.nlm.nih.gov/36321612
Autor:
Paola, Scarparo, Riccardo, Improta, Jeroen, Wilschut, Isabella, Kardys, Wijnand K, Den Dekker, Joost, Daemen, Felix, Zijlstra, Nicolas M, Van Mieghem, Roberto, Diletti
Publikováno v:
Cardiovascular Revascularization Medicine, 41, 144-150. Elsevier Inc.
BACKGROUND/PURPOSE: Direct Stenting (DS) could be associated with reduced distal embolization and improved reperfusion in patients with ST-segment elevation myocardial infarction (STEMI). However, the impact of DS on long-term outcomes remains unclea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::156227687a3ef1f1ab98236dd0bea244
https://pure.eur.nl/en/publications/d7f43afa-89a3-4a05-8c8a-503562185adb
https://pure.eur.nl/en/publications/d7f43afa-89a3-4a05-8c8a-503562185adb
Autor:
Menno van Gameren, Roberto Diletti, Nicolas M. Van Mieghem, Wijnand K den Dekker, Joost Daemen, Paola Scarparo, J. Wilschut, Felix Zijlstra
Publikováno v:
Journal of Thrombosis and Thrombolysis, 54(1), 47-57. Springer Netherlands
Large thrombus burden (LTB) during ST-segment elevation myocardial infarction (STEMI) could translate into worse clinical outcomes. The impact of a LTB in terms of long-term clinical outcomes on different myocardial infarct territories has not yet be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57037d634333fcc72e9973c3c635ad0c
https://pure.eur.nl/en/publications/7f49f981-2590-4866-9854-7432f272d787
https://pure.eur.nl/en/publications/7f49f981-2590-4866-9854-7432f272d787
Autor:
Laurens J.C. van Zandvoort, Isabella Kardys, Kaneshka Masdjedi, Roberto Diletti, Jeroen Wilschut, Nicolas M. Van Mieghem, Miguel E. Lemmert, Koen Ameloot, Paola Scarparo, Maria Natalia Tovar Forero, Joost Daemen, Peter de Jaegere, Wijnand K den Dekker, Felix Zijlstra, Matthew M Balbi
Publikováno v:
American Journal of Cardiology, 125(10), 1486-1491. Elsevier Inc.
The optimal revascularization strategy for residual coronary stenosis following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD) remains controversial. This i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::045db824553469b63c42ebf8e1c2e048
https://doi.org/10.1016/j.amjcard.2020.01.050
https://doi.org/10.1016/j.amjcard.2020.01.050
Autor:
Maria Tovar, Roberto Diletti, Karen Witberg, Nicolas M. Van Mieghem, Kaneshka Masdjedi, Joost Daemen, Jurgen Ligthart, Jeroen Wilschut, Paul Cummins, Wijnand K den Dekker, Paola Scarparo, Felix Zijlstra, Matthew M Balbi
Publikováno v:
Cardiovascular Revascularization Medicine, 35, 110-118. Elsevier Inc.
Background/purpose Identification of the culprit lesion in patients with non-ST elevation acute coronary syndrome (NSTE-ACS) allows appropriate coronary revascularization but may be unclear in patients with multivessel coronary disease (MVD). Therefo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdea5261b1bdae887b7ec94f0d42ccd0
https://pubmed.ncbi.nlm.nih.gov/34872847
https://pubmed.ncbi.nlm.nih.gov/34872847
Autor:
Paola Scarparo, Viviana Maestrini, Giuseppe De Vincentis, Fabio Infusino, Paolo Severino, Viviana Frantellizzi, Massimo Mancone, Francesco Fedele, Lucia Ilaria Birtolo, Nicolò Salvi, Mariani Marco Valerio, Mariateresa Pucci, Sara Cimino
Guidelines for ICD implantation have limitations as implant indication is mainly based on LVEF.CMR and more recently 123-iodine metaiodobenzylguanidine imaging(MIBG)seems to identify patients(pts) at high risk of sudden cardiac death. The aim was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb1b341cab3bcf1064a15d4e8297bae0
http://hdl.handle.net/11573/1390878
http://hdl.handle.net/11573/1390878
Autor:
Viviana Frantellizzi, Francesco Fedele, Derk O. Verschure, Nicolò Salvi, Hein J. Verberne, Paola Scarparo, Massimo Mancone, Alessio Farcomeni, Giuseppe De Vincentis, Danilo Alunni Fegatelli
Publikováno v:
Journal of nuclear cardiology, 26(4), 1188-1196. Springer New York
Background: Despite therapeutic improvement, the prognosis of chronic heart failure (CHF) remains unfavorable partly due to arrhythmia and sudden cardiac death (SCD). This prospective study evaluated myocardial 123I-meta-iodobenzylguanidine (123I-mIB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::130c3e64ea55f70a7e23582e9a7216fc
https://doi.org/10.1007/s12350-018-1258-z
https://doi.org/10.1007/s12350-018-1258-z